Index reshuffle and new credit facility put American Healthcare REIT in focus

American Healthcare REIT (AHR) has moved from several Russell small cap and growth indexes into larger cap and value oriented benchmarks, while amending its credit facility to increase revolving loan capacity and extend maturities.

At a share price of $53.83, American Healthcare REIT has seen its 30 day share price return of 13.37% and year to date share price return of 13.95% coincide with index rebalancing and the expanded credit facility. A 1 year total shareholder return of 49.36% points to stronger long term momentum than the recent 1 day decline of 2.20% might suggest.

If the index reshuffle has you thinking more broadly about where capital is flowing in markets, this is a good moment to check out 20 top founder-led companies

After a 49.36% 1 year total return and a shift into larger cap value indexes, American Healthcare REIT is no longer flying under the radar. Do the current fundamentals and valuation still offer an attractive entry point for new buyers?

Most Popular Narrative: 8.5% Undervalued

With American Healthcare REIT last closing at $53.83 and the most followed fair value estimate sitting at $58.85 per share, the current setup hinges on whether the growth and margin story holds together over time.

The combination of a rapidly growing 80+ demographic and a multi-year period of low new supply in senior housing and skilled nursing is expected to drive a persistent supply-demand imbalance, fueling both occupancy gains and rent growth across American Healthcare REIT's portfolio; this dynamic should underpin above-trend revenue and net operating income growth over the next decade.

Want to see what is built into that growth path for American Healthcare REIT? The valuation leans on specific revenue, earnings, and margin assumptions, plus a rich future earnings multiple and a defined discount rate. Curious how those ingredients line up to reach that fair value and whether the required earnings step up looks achievable on paper?

Result: Fair Value of $58.85 (UNDERVALUED)

However, American Healthcare REIT's story could look different if occupancy progress slows in senior housing or if reimbursement terms for Medicaid and Medicare Advantage become more restrictive.

Another View on American Healthcare REIT's Valuation

While the narrative fair value of $58.85 points to American Healthcare REIT looking 8.5% undervalued, the current P/E of 103.4x sends a very different signal versus the Global Health Care REITs average of 19.9x, the peer average of 43.3x, and a fair ratio of 47.5x. Is the real risk that expectations are simply too high?

Next Steps

With sentiment mixed on American Healthcare REIT, this is a moment to move quickly, review the full picture for yourself, and weigh both the potential upside and the risks before taking a stance, starting with 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond American Healthcare REIT?

If American Healthcare REIT has sharpened your focus, do not stop here. Use the Simply Wall St screener to quickly surface other stocks that fit what you are looking for.

• Target potential turnaround opportunities by reviewing 20 elite penny stocks with strong financials that already show stronger underlying financials than many expect.
• Zero in on quality at a sensible price with the 41 high quality undervalued stocks that filters for solid fundamentals and supportive valuations in one place.
• Prioritise resilience first by checking the 74 resilient stocks with low risk scores that highlights companies with sturdier balance sheets and lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.